Caraco Pharmaceutical (CPD) Granted Tentative FDA Approval for Generic Zyrtec
More News related to CPD
- Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution
- Caraco Pharmaceutical Labs (CPD) Posts Q3 EPS of $0.17
- Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010
- Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
- Morning Movers 9/30: HOKU, ICCC, VSR, CFW, DSCO Higher; CIT, HX, RGN, ICON, APAB, RMTI Lower
Caraco Pharmaceutical Laboratories, Ltd., (Amex: CPD) said the FDA has granted tentative approval for the Company's Abbreviated New Drug Application for Cetirizine Hydrochloride Chewable Tablets, 5 mg and 10 mg. Final approval to market this product is anticipated subsequent to the expiry of patent protection on December 25, 2007.
Related Categories
FDAStocks Mentioned
+0.20Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
